Business Citi Upgrades Merck Price Target Amid Strong Pipeline Prospects Merck & Co., Inc. (NYSE:MRK) has received an upgraded price target from Citi, reflecting the pharmaceutical giant’s robust product pipeline and strengths in oncology.... Editorial7 hours ago